Financial Performance - The company's revenue for Q1 2021 was ¥68,551,289.98, representing a 62.61% increase compared to ¥42,157,957.36 in the same period last year[8]. - Net profit attributable to shareholders reached ¥22,890,054.71, a significant increase of 778.18% from ¥2,606,541.85 year-on-year[8]. - The net profit after deducting non-recurring gains and losses was ¥22,087,724.13, up 1,030.70% from ¥1,953,454.09 in the previous year[8]. - Basic earnings per share rose to ¥0.0882, reflecting a 521.13% increase from ¥0.0142 in the previous year[8]. - Operating profit surged to ¥27,179,641.55, compared to ¥3,194,503.68 in the prior period, indicating a substantial increase of approximately 751.5%[42]. - Net profit for the current period was ¥23,295,330.69, up from ¥2,805,353.41, reflecting an increase of around 728.5%[42]. Cash Flow - The net cash flow from operating activities was ¥29,993,137.21, an increase of 221.88% compared to ¥9,318,196.24 in the same period last year[8]. - Cash flow from operating activities amounted to ¥64,485,326.05, compared to ¥38,925,031.49 in the previous period, indicating an increase of about 65.7%[48]. - Operating cash inflow for the first quarter was CNY 65,825,411.63, an increase from CNY 43,117,982.61 in the previous period, representing a growth of approximately 52.5%[49]. - Net cash flow from operating activities was CNY 29,993,137.21, significantly higher than CNY 9,318,196.24 in the same period last year, indicating a year-over-year increase of about 221.5%[49]. - The company reported a net cash inflow of CNY 221,981,848.95 for the quarter, compared to a net outflow of CNY 6,255,409.46 in the same quarter last year[50]. Assets and Liabilities - Total assets at the end of the reporting period were ¥961,208,203.55, a 31.66% increase from ¥730,072,786.50 at the end of the previous year[8]. - Current assets rose significantly to CNY 306,126,406.50, compared to CNY 77,414,229.84 at the end of 2020, marking an increase of about 295.5%[31]. - The company's total liabilities amounted to CNY 108,932,515.09, up from CNY 100,591,420.27, indicating a rise of about 3.3%[33]. - Shareholders' equity increased to CNY 852,275,688.46 from CNY 629,481,366.23, showing a growth of approximately 35.4%[35]. - The total liabilities to equity ratio improved to approximately 12.8% from 16.0%, indicating a stronger equity position[33]. Market Development - The company added 111 new customers during the reporting period, contributing to an increase in market share[20]. - Revenue for the reporting period increased by 62.61% year-over-year, reaching 68.55 million, attributed to the low revenue base from the previous year due to the pandemic[17]. - Net profit surged by 730.39% year-over-year, amounting to 22.89 million, as a result of enhanced market development and increased customer orders[17]. Future Strategies and Risks - The company aims to achieve a revenue target of 266.59 million and a net profit target of 70.67 million for the year[19]. - Future strategies include strengthening technological innovation and expanding into new markets, particularly in sterilization services and radiation technology applications[21]. - Risks identified include potential pandemic resurgence, market demand fluctuations, and safety/environmental risks associated with nuclear technology applications[24].
中金辐照(300962) - 2021 Q1 - 季度财报